ZEAL Overview
Upcoming Projects (ZEAL)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ZEAL)
-
A Second Opinion: Looking at the potential of long-acting amylin analogs for weight management, with a close look at the phase 1b data on Zealand Pharmaceuticals Petrelintide
Tickers: ZEAL, NVO, LLY
Executed On: Jul 09, 2024 at 04:30 PM EDT -
Digging into the breakthrough results from a survodutide Phase 2 trial sub-analysis in MASH and Liver Fibrosis
Tickers: BOEHRINGER INGELHEIM, ZEAL
Executed On: Jul 03, 2024 at 04:00 PM EDT -
Looking at the potential of long-acting amylin analogs for weight management, with a close look at the phase 1b data on Zealand Pharmaceuticals Petrelintide
Tickers: ZEAL, NVO, LLY
Executed On: Jun 27, 2024 at 10:30 AM EDT -
Discussing the potential of Boehringer's Survodutide in Biopsy-Confirmed F1/F2/F3 MASH with a focus on the Phase II MASH trial
Tickers: BOEHRINGER INGELHEIM, ZEAL
Executed On: Mar 28, 2024 at 11:30 AM EDT
Expired Projects (ZEAL)
-
A look at the portfolio of emerging classes of obesity medications in early development
Tickers: BOEHRINGER INGELHEIM, AMGN, ZEAL, Gubra
Execute By: Oct 22, 2024
Upcoming & Overdue Catalysts (ZEAL)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ZEAL)
-
Zealand Pharma (ZEAL) announces “stalking horse” asset purchase agreement with Valeritas (VLRX)
Tickers: VLRX, ZEAL
Announcement Date: Feb 09, 2020
